StockMarketWire.com - Arix Bioscience said it had re-appointed Joe Anderson as its chief executive after he performed a brief stint as chief investment officer.

Current executive chairman Jonathan Peacock would become non-executive chairman, while Christopher Evans would retire from the board.

Anderson originally became CEO in 2016 but moved into the CIO role last September.

'We have benefited from Joe's focus as CIO over the recent months and the changes announced today build on this and reflect a clear shift towards a leaner organisation that will continue to drive the company's strong growth,' Peacock said.


At 2:40pm: [LON:ARIX] Arix Bioscience Plc share price was -2p at 161p



Story provided by StockMarketWire.com